Vyvanse Denied for Adult ADHD? How to Appeal Your Insurance Denial

Vyvanse (lisdexamfetamine dimesylate) is FDA-approved for attention-deficit/hyperactivity disorder (ADHD) in adults and children, and is also the only FDA-approved medication for moderate-to-severe binge eating disorder. For adults with ADHD, Vyvanse offers sustained, consistent symptom control throughout the day. Despite being an established, widely-prescribed medication, insurance companies frequently deny Vyvanse for adults — often citing cost, step therapy, or formulary preferences. Here's how to appeal.

What Vyvanse Treats and Why Adult ADHD Patients Need It

Vyvanse is a prodrug — lisdexamfetamine is pharmacologically inactive until metabolized in the body to active d-amphetamine. This prodrug design provides a smoother, more gradual onset and longer duration of action compared to immediate-release amphetamines, while also reducing the risk of misuse because it cannot be used intranasally or injected with the same effect as conventional amphetamine salts.

ADHD in adults causes significant impairment in executive functioning, attention, working memory, time management, and impulse control. Untreated or undertreated ADHD leads to occupational dysfunction, relationship problems, accidents, co-occurring psychiatric conditions, and significantly reduced quality of life. Effective treatment is not a matter of convenience — it is a medical necessity.

Vyvanse provides up to 14 hours of effect, covering an adult's full workday and evening responsibilities without the wearing-off effect of shorter-acting stimulants.

Common Denial Reasons for Vyvanse in Adults

Step therapy / generic first: The most common denial reason. Insurers require patients to first try generic ADHD medications — methylphenidate (Ritalin/Concerta generic), mixed amphetamine salts (generic Adderall), or generic atomoxetine (Strattera) — before covering Vyvanse.

Formulary preference for generics: Vyvanse became available in generic form (generic lisdexamfetamine) in 2023. However, Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization criteria may still exist, and some plans have not updated their step therapy protocols.

Adult ADHD diagnosis questioned: Some insurers are skeptical of adult ADHD diagnoses, particularly if they were made recently in adulthood. Documentation of how the diagnosis was made may be required.

Quantity limits: Even when covered, plans may limit Vyvanse to 30 doses per month and deny additional quantities.

Binge eating disorder indication: If prescribed for BED rather than ADHD, the coverage pathway may be different and require specific BED diagnosis documentation.

Step-by-Step: How to Appeal a Vyvanse Adult ADHD Denial

Step 1: Identify the denial reason. Step therapy? Formulary exclusion? Quantity limit? Each requires a different response.

Step 2: Document your prior ADHD medication history. For each prior medication: drug name, dose, duration, and specific reason for failure. Did generic amphetamines cause adverse effects (irritability, cardiovascular concerns, appetite suppression)? Did wearing-off cause functional problems in the evening?

Step 3: Have your prescribing physician or psychiatrist write a Letter of Medical Necessity. The LMN should include your ADHD diagnosis, functional impairment, prior medication history, and specific clinical rationale for Vyvanse over generic alternatives.

Step 4: Document functional impairment. Work performance issues, academic difficulty, driving safety concerns, and occupational risk are all relevant to establishing that ADHD treatment is a medical necessity.

Step 5: If step therapy completion is the issue, confirm whether you've tried required prior medications. If you have, document this clearly. If a required medication is contraindicated (cardiac history, history of psychosis, substance use disorder history favoring the prodrug design of Vyvanse), explain this.

Step 6: File the internal appeal and request peer-to-peer review.

Step 7: File an external appeal if needed.

What to Include in Your Vyvanse Adult ADHD Appeal Letter

• Policy number, member ID, and claim reference
• Vyvanse (lisdexamfetamine) dose and indication: ADHD
• ADHD diagnosis documentation and how it was established
• Functional impairment documentation
• Prior ADHD medication history: drugs, doses, durations, outcomes
• Clinical rationale for Vyvanse specifically (prodrug design, duration of action, specific prior generic failures)
• Letter of Medical Necessity from prescribing physician/psychiatrist
• FDA approval citation for adult ADHD
• Adult ADHD clinical guidelines citation (AHRQ, APA, or CHADD)
• Request for peer-to-peer review

Success Tips for Vyvanse Adult ADHD Appeals

Document what "failure" of generic alternatives actually means. Generic amphetamine salts cause significant rebound effects, afternoon crashes, emotional dysregulation, or interpersonal irritability in many adults. Short-acting generics may not provide adequate coverage for the full workday. Document these specific inadequacies — not just "it didn't work."

Highlight the duration of action. A generic immediate-release stimulant lasting 4–6 hours doesn't cover an adult's full workday plus evening responsibilities. Vyvanse's 14-hour duration is a clinically meaningful distinction for adults who need sustained coverage.

Leverage the prodrug design for abuse history. For patients with a history of substance use disorder or in addiction recovery, Vyvanse's prodrug mechanism is genuinely safer. If this applies, document it as a clinical reason for selecting Vyvanse over conventional amphetamine salts.

Mental health parity applies. ADHD is a mental health condition. Step therapy requirements for ADHD medications that are more restrictive than equivalent requirements for comparable medical conditions may constitute a parity violation under MHPAEA.

Fight Back With ClaimBack

Adult ADHD is a legitimate, well-documented medical condition. If your insurer denied Vyvanse, you have the right to appeal — and ClaimBack can help you do it effectively.

Start your Vyvanse appeal at ClaimBack

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Common Reasons Insurance Claims Are Denied